Number of the records: 1
Oxylipin profiling for clinical research: Current status and future perspectives
- 1.0587350 - FGÚ 2025 RIV GB eng J - Journal Article
Parchem, K. - Letsiou, S. - Petan, T. - Oskolkova, O. - Medina, I. - Kuda, Ondřej - O'Donnell, V. B. - Nicolaou, A. - Fedorova, M. - Bochkov, V. - Gladine, C.
Oxylipin profiling for clinical research: Current status and future perspectives.
Progress in Lipid Research. Roč. 95, July (2024), č. článku 101276. ISSN 0163-7827. E-ISSN 1873-2194
R&D Projects: GA MŠMT(CZ) LX22NPO5104
EU Projects: European Commission(XE) CA19105 - EpiLipidNET
Grant - others:AV ČR(CZ) LQ200111901
Program: Prémie Lumina quaeruntur
Institutional support: RVO:67985823
Keywords : lipid mediators * epilipids * lipidomics * oxylipins * eicosanoids * clinical translation
OECD category: Analytical chemistry
Impact factor: 13.6, year: 2022
Method of publishing: Open access
https://doi.org/10.1016/j.plipres.2024.101276
Oxylipins are potent lipid mediators with increasing interest in clinical research. They are usually measured in systemic circulation and can provide a wealth of information regarding key biological processes such as inflammation, vascular tone, or blood coagulation. Although procedures still require harmonization to generate comparable oxylipin datasets, performing comprehensive profiling of circulating oxylipins in large studies is feasible and no longer restricted by technical barriers. However, it is essential to improve and facilitate the biological interpretation of complex oxylipin profiles to truly leverage their potential in clinical research. This requires regular updating of our knowledge about the metabolism and the mode of action of oxylipins, and consideration of all factors that may influence circulating oxylipin profiles independently of the studied disease or condition. This review aims to provide the readers with updated and necessary information regarding oxylipin metabolism, their different forms in systemic circulation, the current limitations in deducing oxylipin cellular effects from in vitro bioactivity studies, the biological and technical confounding factors needed to consider for a proper interpretation of oxylipin profiles.
Permanent Link: https://hdl.handle.net/11104/0354631
File Download Size Commentary Version Access 24_0062_0587350.pdf 0 3.6 MB Publisher’s postprint open-access
Number of the records: 1